ResMed Inc/ US7611521078 /
2024-11-08 9:59:58 PM | Chg. +3.95 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
252.37USD | +1.59% | 39,851 Turnover: 10.07 mill. |
-Bid Size: - | -Ask Size: - | 37.05 bill.USD | 0.76% | 36.37 |
Assets
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 417.3350 | 463.4900 | 498.1810 | 537.8560 | 548.0250 | ||||||
Intangible Assets | 448.1680 | 392.5820 | 345.9440 | 552.3410 | 485.9040 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 3,063.9170 | 3,153.3680 | 3,164.3750 | 4,383.8780 | 4,514.6750 | ||||||
Inventories | 416.9150 | 457.0330 | 743.9100 | 998.0120 | 822.2500 | ||||||
Accounts Receivable | 474.6430 | 614.2920 | 575.9500 | 704.9090 | 837.2750 | ||||||
Cash and Cash Equivalents | 463.1560 | 295.2780 | 273.7100 | 227.8910 | 238.3610 | ||||||
Current Assets | 1,523.4590 | 1,574.7570 | 1,931.4780 | 2,367.8300 | 2,357.7190 | ||||||
Total Assets | 4,587.3760 | 4,728.1250 | 5,095.8530 | 6,751.7080 | 6,872.3940 |
Liabilities
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 135.7860 | 138.0080 | 159.2450 | 150.7560 | 237.7280 | ||||||
Long-term debt | 1,164.1330 | 643.3510 | 765.3250 | 1,431.2340 | 697.3130 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 2,090.3490 | 1,842.4460 | 1,735.1020 | 2,621.8050 | 2,008.3510 | ||||||
Share Capital | .5800 | .5830 | .5860 | .5880 | .5880 | ||||||
Total Equity | 2,497.0270 | 2,885.6790 | 3,360.7510 | 4,129.9030 | 4,864.0430 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 4,587.3760 | 4,728.1250 | 5,095.8530 | 6,751.7080 | 6,872.3940 |
Income Statement
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2,957.0130 | 3,196.8250 | 3,578.1270 | 4,222.9930 | 4,685.2970 | ||||||
Depreciation (total) | 154.8500 | 156.7580 | 159.6090 | 165.1560 | 176.8700 | ||||||
Operating Result | 809.6590 | 903.6780 | 1,000.2860 | 1,131.8710 | 1,319.8930 | ||||||
Interest Income | -39.3560 | -23.6270 | -22.3120 | -47.3790 | - | ||||||
Income Before Taxes | 733.0880 | 883.6620 | 960.4830 | 1,101.6640 | 1,264.7980 | ||||||
Income Taxes | 111.4140 | 409.1570 | 181.0460 | 204.1080 | 243.8470 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 621.6740 | 474.5050 | 779.4370 | 897.5560 | 1,020.9510 |
Per Share
Cash Flow
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 802.2550 | 736.7180 | 351.1470 | 693.2990 | 1,401.2600 | ||||||
Cash Flow from Investing Activities | -179.8610 | -158.4620 | -229.9180 | -1,159.8450 | -269.7840 | ||||||
Cash Flow from Financing | -317.2860 | -764.6320 | -128.3630 | 422.8740 | -1,119.2870 | ||||||
Decrease / Increase in Cash | 316.0280 | -167.8780 | -21.5680 | -45.8190 | 10.4700 | ||||||
Employees | 7,700 | - | - | - | - |